Statin Use in Cervical Artery Dissection and Subsequent Ischemic Stroke.

Area of Science:

• Neurology
• Cardiology
• Vascular Medicine

Background:

• Cervical artery dissection (CAD) is a significant cause of ischemic stroke, particularly in younger adults.
• The efficacy of statin therapy in preventing recurrent ischemic strokes following CAD is not well-established.

Purpose of the Study:

• To investigate the impact of statin therapy on the risk of subsequent ischemic stroke in patients with non-traumatic cervical artery dissection.
• To evaluate the effect of statins on major hemorrhage, mortality, and functional outcomes in this patient population.

Main Methods:

• Secondary analysis of the Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection (STOP-CAD) study.
• Included 2610 patients with ischemic stroke from non-major trauma-related CAD, stratified by statin use at discharge.
• Sensitivity analysis based on statin intensity (high, moderate, low, or none).

Main Results:

• No significant difference in subsequent ischemic strokes between statin users (3.1%) and non-users (3.3%) (aHR 0.73; 95% CI, 0.43-1.24; p=0.25).
• No significant differences observed in major hemorrhage, mortality, or 90-day functional outcomes between the groups.

Conclusions:

• Statin therapy did not demonstrate a significant reduction in recurrent ischemic stroke, major hemorrhage, mortality, or improved functional outcomes in patients with CAD.
• Findings suggest that the benefits of statins in CAD-related ischemic strokes are less clear compared to general ischemic stroke populations.
• Highlights the need for individualized treatment strategies and further research to optimize secondary prevention in CAD.